The global pharmacy benefit management market size is expected to reach around US$ 757.05 billion by 2030 and is expected to grow at an impressive double-digit rate of 5.5% from 2022 to 2030.
The rapidly growing prevalence of various chronic diseases such as cancer, cardiovascular diseases, respiratory diseases, and diabetes are expected to boost the growth of the global pharmacy benefit management market during the forecast period.
The study includes drivers and restraints of this market. The study provides an analysis of the global pharmacy benefit management market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 150+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Report Scope of the Pharmacy Benefit Management Market
| Report Coverage | Details |
| Market Size by 2030 | USD 757.05 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.5% |
| Largest Market | Asia Pacific |
| Fastest Growing Region | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1770
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global pharmacy benefit management market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global pharmacy benefit management market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global pharmacy benefit management market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmacy benefit management are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global pharmacy benefit management market include:
- CVS Health
- SS&C Technologies, Inc.
- Anthem Inc.
- Medimpact
- Express Scripts Holding Company
- Benecard Services, LLC
- CaptureRx Inc.
- Change Healthcare
- OptumRx, Inc.
- Cigna
Market Segmentation:
By Service
- Specialty Pharmacy Services
- Benefit Plan Design & Administration
- Formulary Management
- Pharmacy Claims Processing
- Others
By Service Provider
- Retail Pharmacies
- Insurance Companies
- Standalone Pharmacy Benefit Management Providers
By Business Model
- Government Health Programs
- Employer-sponsored Programs
- Health Insurance Management
Regional Analysis:
The geographical analysis of the global pharmacy benefit management market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global pharmacy benefit management Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global pharmacy benefit management market in 2030?
- What is the expected CAGR for the pharmacy benefit management market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global pharmacy benefit management market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmacy Benefit Management Market
5.1. COVID-19 Landscape: Pharmacy Benefit Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmacy Benefit Management Market, By Service
8.1. Pharmacy Benefit Management Market, by Service, 2022-2030
8.1.1 Specialty Pharmacy Services
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Benefit Plan Design & Administration
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Formulary Management
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Pharmacy Claims Processing
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmacy Benefit Management Market, By Service Provider
9.1. Pharmacy Benefit Management Market, by Service Provider, 2022-2030
9.1.1. Retail Pharmacies
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Insurance Companies
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Standalone Pharmacy Benefit Management Providers
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmacy Benefit Management Market, By Business Model
10.1. Pharmacy Benefit Management Market, by Business Model, 2022-2030
10.1.1. Government Health Programs
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Employer-sponsored Programs
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Health Insurance Management
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Pharmacy Benefit Management Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
Chapter 12. Company Profiles
12.1. CVS Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SS&C Technologies, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Anthem Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medimpact
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Express Scripts Holding Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Benecard Services, LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CaptureRx Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Change Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OptumRx, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Cigna
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments